The biotechnology company's potential treatment for the genetic disorder Prader-Willi Syndrome needs further study before receiving a U.S. regulatory ...
News
- McAfee, GameStop rise; AnaptysBio, Soleno fall
- Ardelyx: Q4 Earnings Snapshot
The biotechnology company posted revenue of $1.8 million in the period, which also missed Street forecasts. Three analysts surveyed by Zacks ...
- Texas Biomedical Research CEO discusses masks, COVID vaccines, World Affairs Council award
SAN ANTONIO (KTSA News) – The leader of a local research establishment which played a role in the development of a COVID-19 vaccine is being ...
- Texas Startup Manifesto 2.0
Austin, Dallas, Houston, San Antonio form a massive startup Megalopolis ... “Building on five multi-million dollar exits in the last five years in biotech ...
- This Could Be A Watershed Year For Infinity Pharma Stock
... and "nabpaclitaxel" products of Arcus Bioscience for front-line triple negative breast cancer. A slide from the San Antonio Breast Cancer Symposium ...